Medofulvin (Griseofulvin)

Griseofulvin interferes with fungal cell division by binding to microtubules, which blocks mitotic spindle formation. It also disrupts the fungus’s ability to metabolize keratin, a protein found in skin, hair and nails, thereby limiting fungal growth and allowing the immune system to clear the infection.

The dosage of Medofulvin is individualized by the prescribing clinician based on the type and severity of the infection, patient age, weight and renal or hepatic function. Only a qualified healthcare professional should determine the appropriate dose and treatment duration.

Safety data for griseofulvin in pregnancy are limited, and the drug is generally avoided unless the potential benefit justifies the risk. It is excreted in breast milk, so breastfeeding mothers should discuss alternatives with their healthcare provider.

To order Medofulvin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with azole antifungals, griseofulvin has a unique mechanism that targets fungal microtubules and keratin metabolism. It is often chosen for chronic dermatophyte infections where long‑term therapy is needed, whereas azoles may be preferred for rapid systemic fungal infections. Choice depends on infection type, patient factors and resistance patterns.

Medofulvin tablets should be stored at ambient temperature, preferably below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Medofulvin is taken orally, usually with a full glass of water. It may be recommended to be taken with food to improve absorption, but patients should follow the specific instructions provided by their prescriber or pharmacist.

Serious adverse events include hepatotoxicity, which may present as jaundice or elevated liver enzymes, and bone‑marrow suppression leading to anemia or leukopenia. Rarely, severe allergic reactions such as angioedema or anaphylaxis can occur. Patients should seek immediate medical attention if they notice these symptoms.

Medofulvin is contraindicated in patients with known hypersensitivity to griseofulvin or any component of the formulation. Caution is advised for individuals with severe liver disease, bone‑marrow disorders, or those taking medications that have major interactions, such as warfarin or oral contraceptives, unless closely monitored.